Contact us for investor information. More specific information regarding the ulcerative colitis therapy, the clinical plan, marketing and sales projections will be made available based on an agreement of confidentiality.

Keystone Biologics, Inc.
6 Traber Lane, Suite 201
Spring City, Pennsylvania  19475

phone: 610.469.6850
email: info@keystonebiologics.com